Company

Daiichi Sankyo is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company's roots extend back to the year 1899 and the early days of industrialisation of the pharmaceutical sector. more...

Research and development pipeline

While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, Daiichi Sankyo is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. more...

Business strategy

Like other research-based pharmaceutical companies, Daiichi Sankyo's engaged in high-risk/high-return research and development investments. more...

Besides the company's world headquarters in Tokyo, the Daiichi Sankyo Group has affiliates in almost 60 countries and in all continents. Its German and European base is located in Munich. more...

Daiichi Sankyo Europe has two production facilities, both approved by national and international authorities such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMEA) more...

Latest news